Display Settings:

Format

Send to:

Choose Destination
    Kidney Int. 2011 Jan;79(1):10-3.

    20-HETE in acute kidney injury.

    Source

    Department of Pharmacology, University of Mississippi Medical Center, Jackson, Mississippi 39216-4505, USA. rroman@umc.edu

    Abstract

    Ischemia/reperfusion injury (IRI) is a common cause of acute kidney injury (AKI) that is associated with a patient mortality of up to 50%. Currently there are not effective pharmacologic therapies for AKI. This Commentary highlights recent evidence indicating that 20-HETE plays an important role in IRI and that drugs that target this pathway have potential as therapeutic agents for AKI.

    PMID:
    21157458
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3146060
    Free PMC Article

    Images from this publication.See all images (1) Free text

    Figure 1

      Supplemental Content

      Icon for Nature Publishing Group Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk